A Stanford geneticist is leveraging Co-Scientist to accelerate drug discovery for liver fibrosis. This AI-powered platform aids in identifying repurposed medications, potentially offering new therapeutic avenues for chronic liver disease. The application of advanced AI in this specific biological challenge highlights emerging interdisciplinary research trends.
Opening Kapyn…